The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good
- PMID: 32251726
- PMCID: PMC7129235
- DOI: 10.1016/j.phrs.2020.104776
The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good
Conflict of interest statement
Declaration of Competing Interest There are no conflicts to declare.
Comment in
-
Reply to "The use of traditional Chinese medicines to treat SARS-CoV-2 may cause more harm than good".Pharmacol Res. 2020 Jul;157:104775. doi: 10.1016/j.phrs.2020.104775. Epub 2020 Apr 3. Pharmacol Res. 2020. PMID: 32251725 Free PMC article. No abstract available.
Comment on
-
Traditional Chinese medicine for COVID-19 treatment.Pharmacol Res. 2020 May;155:104743. doi: 10.1016/j.phrs.2020.104743. Epub 2020 Mar 4. Pharmacol Res. 2020. PMID: 32145402 Free PMC article. No abstract available.
References
-
- Enomoto Y.M., Nakamura Y.M.P., Enomoto N.M.P., Fujisawa T.M.P., Inui N.M.P., Suda T. Japanese herbal medicine-induced pneumonitis: a review of 73 patients. Respir. Investig. 2017;55:138–144. - PubMed
-
- Sakamoto O., Ichikado K., Kohrogi H., Suga M. Clinical and CT characteristics of Chinese medicine-induced acute respiratory distress syndrome. Respirology. 2003;8:344–350. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous